Lenox Wealth Advisors’s Radius Health, Inc. RDUS Stock Holding History

Lenox Wealth Advisors’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-365	Closed	-$6K	–	401
2018 Q3	$6K	Hold	365	–	–	﹤0.01%	303
2018 Q2	$11K	Sell	365 -40	-10%	-$1.26K	﹤0.01%	348
2018 Q1	$15K	Buy	405 +318	+366%	+$11.5K	﹤0.01%	309
2017 Q4	$3K	Buy	+87	New	+$2.73K	﹤0.01%	305

Other funds holding RDUS

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lenox Wealth Advisors's RDUS Position: Q4 2018 in Review

Lenox Wealth Advisors sold out of Radius Health, Inc. (RDUS) in Q4 2018, closing a stake of 365 shares — an estimated $6K sold.

Lenox Wealth Advisors first reported a position in RDUS in Q4 2017 and held it in 4 quarters. The position peaked at $15K in Q1 2018. 123 funds tracked by Wall St. Rank hold RDUS as of Q4 2018.

Lenox Wealth Advisors reported no remaining Radius Health, Inc. position as of Q4 2018 after selling out during the quarter.
Lenox Wealth Advisors sold 365 Radius Health, Inc. shares in Q4 2018, an estimated $6K.
Lenox Wealth Advisors first reported a position in Radius Health, Inc. in Q4 2017 and held it in 4 quarters.
Lenox Wealth Advisors's Radius Health, Inc. position peaked at $15K in Q1 2018.
123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2018.

Based on Lenox Wealth Advisors's 13F filing for Q4 2018, filed 9 Jan 2019.